fda stance on compounded semaglutide warns about versions of popular weight loss drugs Despite FDA ruling, compounded GLP-1s

Over a third of the participants receiving the drug lost more than 20 percent of their weight

These effects explain most early weight loss on therapy

Asking about the specific compounding pharmacy, its quality standards, and the drug preparation protocol is a reasonable and appropriate question before starting

Include current medications, kidney or liver disease history, pancreatitis or gallbladder history, pregnancy plans, eating pattern changes, and prior gastrointestinal intolerance

Med., vol

Both start at a dose intended to be well below the therapeutic threshold, primarily serving as an acclimation period for the GI system